Citations

Showing 10 of 108083 citations.

Raman Computational and Experimental Studies of Dopamine Detection
Ciubuc, John, Bennet, Kevin E. , Alonzo, Matthew , Durrer, William, Manciu, Felicia , Manciu, Felicia S , Qiu, Chao

Mayo Clinic

Biosensors | September 28, 2017 | Volume: 7 | Issue: 4 | Pages: 43

10.3390/bios7040043 | PMID 28956820 Get It

A combined theoretical and experimental analysis of dopamine (DA) is presented in this work with the objective of achieving more accurate detection and monitoring of this neurotransmitter at very low concentrations, specific to physiological levels. Surface-enhanced Raman spectroscopy on silver nanoparticles was employed for recording DA concentrations as low as 10−11 molar. Quantum chemical density functional calculations were carried out using Gaussian-09 analytical suite software. Relatively good agreement between the simulated and experimentally determined results indicates the presence of different DA molecular forms, such as uncharged DA±, anionic DA−, and dopaminequinone. Disappearance of the strongest bands of dopamine around 750 cm−1 and 790 cm−1, which suggests its adsorption onto the metallic surface, is not only consistent with all of these DA configurations, but also provides additional information about the analyte’s redox process and voltammetric detection. On the other hand, occurrence of the abovementioned Raman lines could indicate the formation of multilayers of DA or its presence in a cationic DA+ form. Thus, through coordinated experiment and theory, valuable insights into changes observed in the vibrational signatures of this important neurotransmitter can be achieved for a better understanding of its detection at physiological levels, which is crucial if further optovoltammetric medical device development is envisioned.
Heat stress induced, ligand-independent MET and EGFR signalling in hepatocellular carcinoma
Jondal, Danielle E. , Butters, Kim A., Anderson, Jill , Stokes, Matthew P. , Jia, Xiaoying , Grande, Joseph P. , Roberts, Lewis R. , Callstrom, Matthew R. , Woodrum, David A. , Knudsen, Bruce E. , Anderson, Jill L, Roberts, Lewis R , Thompson, Scott M.

Mayo Clinic

International Journal of Hyperthermia | September 28, 2017 | Volume: 34 | Issue: 6 | Pages: 812-823

10.1080/02656736.2017.1385859 | PMID 28954551 Get It

Perioperative Management of Female Hormone Medications
Seim, Lynsey A. , Irizarry-Alvarado, Joan M., Seim, Lynsey

Mayo Clinic

Current Clinical Pharmacology | September 28, 2017 | Volume: 12 | Issue: 3 | Pages: 188-193

10.2174/1574884712666170927115947 | PMID 28969534 Get It

Anti-cytosolic 5′-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseases
Liewluck, Teerin , Liewluck, T

Mayo Clinic

Neurology | September 28, 2017 | Volume: 89 | Issue: 19 | Pages: 2017-2018

10.1212/wnl.0000000000004610 | PMID 28954884 Get It

Optimizing Test Utilization in the Clinical Microbiology Laboratory: Tools and Opportunities
Pritt, Bobbi S. , Pritt, Bobbi S

Mayo Clinic

Journal of Clinical Microbiology | September 28, 2017 | Volume: 55 | Issue: 12 | Pages: 3321-3323

10.1128/jcm.01332-17 | PMID 28954899 Get It

ABSTRACT Optimal laboratory test utilization is important for providing high-quality clinical care and efficiently using limited health care resources. While microbiologists have long been advocates for appropriate laboratory test utilization, the widespread availability of electronic medical records capable of supporting clinician order entry and of clinical decision support tools (CDSTs) has provided expanded opportunities for implementing effective, automated test stewardship protocols. D. Nikolic et al. (J. Clin. Microbiol. 55:3350–3354, 2017, https://doi.org/10.1128/JCM.01052-17 ) describe the results of implementing a CDST at their institution to curtail stool microbiology testing for patients hospitalized for more than 3 days. Their intervention significantly decreased unnecessary test orders and saved their laboratory over $8,000 in reagent and labor costs during an 11-month postintervention period. That report provides an excellent example of how clinical microbiologists can use electronic tools to optimize laboratory test utilization in their health care system.
Door-to-Needle Time in Acute Stroke Treatment and the “July Effect”
Carpani, Federico , Hawkes, Maximiliano A. , Farez, Mauricio , Ameriso, Sebastian Francisco

Mayo Clinic

The Neurohospitalist | September 28, 2017 | Volume: 8 | Issue: 1 | Pages: 24-28

10.1177/1941874417733108 | PMID 29276559 Get It

Intravenous thrombolysis improves outcomes in acute ischemic stroke in a time-dependent fashion. As in teaching hospitals, clinical outcomes may worsen due to the arrival of new inexperienced house staff early in the academic year (July effect, JE), we evaluated the impact of the “JE” on the door-to-needle time for intravenous thrombolysis and other stroke outcomes. In this retrospective cohort study, we assessed all acute ischemic strokes treated with intravenous thrombolysis between July 2003 and June 2016. Among 101 patients, there was no detrimental July effect on the door-to-needle time, rate of thrombolysis within 60 minutes of arrival, thrombolysis of stroke mimics, post-thrombolysis intracranial hemorrhages, National Institutes of Health Stroke Scale, and modified Rankin Scale outcomes.
Seven tips for developing and maintaining a high performance sports medicine team
Gabbett, Tim J. , Kearney, Simon, Bisson, Leslie J. , Sikka, Robby , Winder, Nathan, Sedgwick, Craig, Hollis, Ed , Bettle, Jeremy M., Collins, Joe T.

Mayo Clinic

British Journal of Sports Medicine | September 27, 2017 | Volume: 52 | Issue: 10 | Pages: 626-627

10.1136/bjsports-2017-098426 | PMID 28954792 Get It

CRISPR Genome-Wide Screening Identifies Dependence on the Proteasome Subunit PSMC6 for Bortezomib Sensitivity in Multiple Myeloma
Shi, Chang-Xin, Zhu, Yuan Xiao , Bruins, Laura A., Jedlowski, Patrick , Votruba, Patrick G., Luo, Moulun , Ahmann, Jonathan M., Braggio, Esteban , Stewart, A. Keith, Stewart, Robert A, Ahmann, Jonathan, Braggio, Esteban , Kortüm, K. Martin , Stewart, Robert

Mayo Clinic

Molecular Cancer Therapeutics | September 27, 2017 | Volume: 16 | Issue: 12 | Pages: 2862-2870

10.1158/1535-7163.mct-17-0130 | PMID 28958990 Get It

Abstract Bortezomib is highly effective in the treatment of multiple myeloma; however, emergent drug resistance is common. Consequently, we employed CRISPR targeting 19,052 human genes to identify unbiased targets that contribute to bortezomib resistance. Specifically, we engineered an RPMI8226 multiple myeloma cell line to express Cas9 infected by lentiviral vector CRISPR library and cultured derived cells in doses of bortezomib lethal to parental cells. Sequencing was performed on surviving cells to identify inactivated genes responsible for drug resistance. From two independent whole-genome screens, we selected 31 candidate genes and constructed a second CRISPR sgRNA library, specifically targeting each of these 31 genes with four sgRNAs. After secondary screening for bortezomib resistance, the top 20 “resistance” genes were selected for individual validation. Of these 20 targets, the proteasome regulatory subunit PSMC6 was the only gene validated to reproducibly confer bortezomib resistance. We confirmed that inhibition of chymotrypsin-like proteasome activity by bortezomib was significantly reduced in cells lacking PSMC6. We individually investigated other members of the PSMC group (PSMC1 to 5) and found that deficiency in each of those subunits also imparts bortezomib resistance. We found 36 mutations in 19S proteasome subunits out of 895 patients in the IA10 release of the CoMMpass study (https://themmrf.org). Our findings demonstrate that the PSMC6 subunit is the most prominent target required for bortezomib sensitivity in multiple myeloma cells and should be examined in drug-refractory populations. Mol Cancer Ther; 16(12); 2862–70. ©2017 AACR.
An Efficient Test for Gene-Environment Interaction in Generalized Linear Mixed Models with Family Data
Mazo-Lopera, Mauricio Alejandro , Coombes, Brandon J. , Mazo Lopera, Mauricio A , de Andrade, Mariza, Andrade, Mariza de , Coombes, Brandon J

Mayo Clinic

International Journal of Environmental Research and Public Health | September 27, 2017 | Volume: 14 | Issue: 10 | Pages: 1134

10.3390/ijerph14101134 | PMID 28953253 Get It

Gene-environment (GE) interaction has important implications in the etiology of complex diseases that are caused by a combination of genetic factors and environment variables. Several authors have developed GE analysis in the context of independent subjects or longitudinal data using a gene-set. In this paper, we propose to analyze GE interaction for discrete and continuous phenotypes in family studies by incorporating the relatedness among the relatives for each family into a generalized linear mixed model (GLMM) and by using a gene-based variance component test. In addition, we deal with collinearity problems arising from linkage disequilibrium among single nucleotide polymorphisms (SNPs) by considering their coefficients as random effects under the null model estimation. We show that the best linear unbiased predictor (BLUP) of such random effects in the GLMM is equivalent to the ridge regression estimator. This equivalence provides a simple method to estimate the ridge penalty parameter in comparison to other computationally-demanding estimation approaches based on cross-validation schemes. We evaluated the proposed test using simulation studies and applied it to real data from the Baependi Heart Study consisting of 76 families. Using our approach, we identified an interaction between BMI and the Peroxisome Proliferator Activated Receptor Gamma (PPARG) gene associated with diabetes.
Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia
Kahn, Allon , Al-Qaisi, Mohanad, Kommineni, Vishnu, Callaway, Jonathan K., Boroff, Erika, Burdick, George E., Lam‐Himlin, Dora , Temkit, M’hamed , Vela, Marcelo F. , Ramirez, Francisco C. , Kahn, Allon

Mayo Clinic

Diseases of the Esophagus | September 27, 2017 | Volume: 31 | Issue: 4 | Pages: No page available

10.1093/dote/dox120 | PMID 29036431 Get It